New Republic Capital, LLC

Position in ABBV — AbbVie Inc.

CIK 1989988 CHARLOTTE, NC

Position in ABBV

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$990,455

-$458,463 QoQ

Shares Held

3,936

-40.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#2,552

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

New Republic Capital, LLC holds $13,477,197 across 11 Drug Manufacturers - General names. ABBV ranks #6 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,001	$3,599,489
2	JNJ	Johnson & Johnson	8,090	$2,054,617
3	AMGN	Amgen Inc	4,966	$1,798,287
4	MRK	Merck & Co., Inc.	11,402	$1,465,157
5	BMY	Bristol Myers Squibb Co	17,698	$1,019,758
6	ABBV	AbbVie Inc. This page	3,936	$990,455
7	PFE	Pfizer Inc	25,574	$615,821
8	NVS	Novartis AG	3,729	$584,408

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$990,455	3,936	-40.9%	Shares	Sole	2026-07-31
2026-03-31	$1,448,918	6,662	+4.8%	Shares	Sole	2026-05-01
2025-12-31	$1,452,739	6,358	+60.2%	Shares	Sole	2026-02-10
2025-09-30	$918,982	3,969	+2.4%	Shares	Sole	2025-10-27
2025-06-30	$719,463	3,876	+1.6%	Shares	Sole	2025-08-12
2025-03-31	$799,109	3,814	+3.2%	Shares	Sole	2025-05-07
2024-12-31	$656,423	3,694	-0.6%	Shares	Sole	2025-01-29
2024-09-30	$734,033	3,717	+2.1%	Shares	Sole	2024-11-04
2024-06-30	$624,161	3,639	+0.7%	Shares	Sole	2024-08-14
2024-03-31	$657,927	3,613	+2.2%	Shares	Sole	2024-05-07
2023-12-31	$547,663	3,534	+29.7%	Shares	Sole	2024-02-12
2023-09-30	$406,039	2,724	-6.4%	Shares	Sole	2023-11-14
2023-06-30	$391,929	2,909	-4.8%	Shares	Sole	2023-08-14
2023-03-31	$487,034	3,056	+57.5%	Shares	Sole	2023-09-12
2022-12-31	$313,523	1,940	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.